The HPV vaccine has been part of the NHS’s vaccination schedule since 2008. Now, in England, only one dose is needed for protection against the virus. Image credit: Shutterstock/MAGNIFIER

Teenagers and adults under the age of 25 at higher risk of sexually transmitted disease transmission will receive a single dose of the human papillomavirus (HPV) vaccine from September 2023.

Whilst teenagers and eligible gay, bisexual, and other men who have sex with men (GBMSM) under the age of 25 will shift from two doses to one, immunosuppressed individuals (or those known to be HIV positive) will continue a 3-dose schedule.

Go deeper with GlobalData

Premium Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

The change in guidelines followed updated advice from Joint Committee on Vaccination and Immunisation (JCVI), which reviewed global evidence, including a review published by the World Health Organisation (WHO), that shows a single dose offers comparable protection to two doses. The WHO recommendation for a one-dose schedule for girls ages 9–14 years was released in December last year. A paper published this month in The Lancet also added to the overwhelming evidence indicating that a single dose does the trick.

The shift by the UK Health Security Agency (UKHSA) follows moves already made by Scotland and Wales to half the HPV vaccine dose.

It is estimated around 80% of people will be infected with HPV at some point in their life. The virus is asymptomatic and usually does not cause problems. However, some strains of the virus can cause cervical cancer and, less frequently, cancers of the vagina, vulva, penis, and anus.

See Also:

Currently, the NHS uses Gardasil 9 developed by MSD, which is also known as Merck in US and Canada.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

“The HPV vaccination programme is one of the most successful in the world and has dramatically lowered the rates of cervical cancer and harmful infections in both women and men – preventing many cancers and saving lives,” said Dr. Vanessa Saliba, Immunisation Consultant Epidemiologist at the UKHSA.

“The latest evidence shows that one dose provides protection as robust as 2 doses. This is excellent news for young people.”